149 related articles for article (PubMed ID: 17013439)
1. [Determinants of depression in 111 Italian patients with systemic sclerosis].
Beretta L; Astori S; Ferrario E; Caronni M; Raimondi M; Scorza R
Reumatismo; 2006; 58(3):219-25. PubMed ID: 17013439
[TBL] [Abstract][Full Text] [Related]
2. Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample.
Tedeschini E; Pingani L; Simoni E; Ferrari D; Giubbarelli C; Giuggioli D; Lumetti F; Rigatelli M; Ferri C; Ferrari S
Int J Rheum Dis; 2014 Feb; 17(2):186-94. PubMed ID: 24576274
[TBL] [Abstract][Full Text] [Related]
3. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms associated with scleroderma.
Roca RP; Wigley FM; White B
Arthritis Rheum; 1996 Jun; 39(6):1035-40. PubMed ID: 8651968
[TBL] [Abstract][Full Text] [Related]
5. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma.
Matsuura E; Ohta A; Kanegae F; Haruda Y; Ushiyama O; Koarada S; Togashi R; Tada Y; Suzuki N; Nagasawa K
J Rheumatol; 2003 Aug; 30(8):1782-7. PubMed ID: 12913935
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.
Danieli E; Airò P; Bettoni L; Cinquini M; Antonioli CM; Cavazzana I; Franceschini F; Cattaneo R
Clin Rheumatol; 2005 Feb; 24(1):48-54. PubMed ID: 15300468
[TBL] [Abstract][Full Text] [Related]
7. Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors.
Ostojic P; Zivojinovic S; Reza T; Damjanov N
Mod Rheumatol; 2010 Aug; 20(4):353-7. PubMed ID: 20336476
[TBL] [Abstract][Full Text] [Related]
8. Association between cortisol levels and pain threshold in systemic sclerosis and major depression.
Bagnato G; Cordova F; Sciortino D; Miceli G; Bruno A; Ferrera A; Sangari D; Coppolino G; Muscatello MRA; Pandolfo G; Zoccali RA; Roberts WN
Rheumatol Int; 2018 Mar; 38(3):433-441. PubMed ID: 29086069
[TBL] [Abstract][Full Text] [Related]
9. Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.
Türk İ; Cüzdan N; Çiftçi V; Arslan D; Doğan MC; Unal İ
Clin Rheumatol; 2020 Jan; 39(1):57-67. PubMed ID: 31129793
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
11. Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.
Pauling JD; Reilly E; Smith T; Frech TM
Arthritis Care Res (Hoboken); 2019 Aug; 71(8):1119-1126. PubMed ID: 30133174
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Severity of Depression and Anxiety in Patients With Systemic Sclerosis: An Epidemiologic Survey and Investigation of Clinical Correlates.
Faezi ST; Paragomi P; Shahali A; Akhlaghkhah M; Akbarian M; Akhlaghi M; Kheirandish M; Gharibdoost F
J Clin Rheumatol; 2017 Mar; 23(2):80-86. PubMed ID: 28099215
[TBL] [Abstract][Full Text] [Related]
13. Common Causes of Pain in Systemic Sclerosis: Frequency, Severity, and Relationship to Disease Status, Depression, and Quality of Life.
Ostojic P; Jankovic K; Djurovic N; Stojic B; Knezevic-Apostolski S; Bartolovic D
Pain Manag Nurs; 2019 Aug; 20(4):331-336. PubMed ID: 31103501
[TBL] [Abstract][Full Text] [Related]
14. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis.
Schieir O; Thombs BD; Hudson M; Boivin JF; Steele R; Bernatsky S; Hanley J; Baron M;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):409-17. PubMed ID: 20391488
[TBL] [Abstract][Full Text] [Related]
16. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample.
Leavens A; Patten SB; Hudson M; Baron M; Thombs BD;
Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1195-201. PubMed ID: 22438281
[TBL] [Abstract][Full Text] [Related]
17. Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem.
Kwakkenbos L; van Lankveld WG; Vonk MC; Becker ES; van den Hoogen FH; van den Ende CH
J Psychosom Res; 2012 Mar; 72(3):199-204. PubMed ID: 22325699
[TBL] [Abstract][Full Text] [Related]
18. Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis.
Pauling JD; Reilly E; Smith T; Frech TM
J Rheumatol; 2019 Oct; 46(10):1326-1334. PubMed ID: 30824643
[TBL] [Abstract][Full Text] [Related]
19. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
20. Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.
Pauling JD; Yu L; Frech TM; Herrick AL; Hummers LK; Shah AA; Denton CP; Saketkoo LA; Withey J; Khanna D; Domsic RT
Rheumatology (Oxford); 2024 May; 63(5):1281-1290. PubMed ID: 37481713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
